Research location

Exeter

England, United Kingdom

Published trials21

Site observations21

Linked trials published21

Page1 / 1

Research activity in Exeter

England, United Kingdom

CureCurrent currently publishes aggregate city-level research activity for this location: 21 trials and 21 site observations.

The map is centered on registry-derived city coordinates. Circle size reflects published trial activity.

Below are current trials with one or more ClinicalTrials.gov site observations in this city. Results are paginated 50 per page, with recruiting studies shown first.

Trials with sites in Exeter

21 linked trials · page 1 of 1

ONC-392 Versus Docetaxel in Metastatic NSCLC That Progressed on PD-1/PD-L1 InhibitorsNCT05671510 · 2023-06-28 · 1 site observation

ACTIVE_NOT_RECRUITING

Study of Chemoradiotherapy With or Without Pembrolizumab (MK-3475) For The Treatment of Locally Advanced Cervical Cancer (MK-3475-A18/KEYNOTE-A18/ENGOT-cx11/GOG-3047)NCT04221945 · 2020-05-12 · 1 site observation

Fulvestrant +/- Vandetanib in Advanced Aromatase Inhibitor Resistant Breast CancerNCT02530411 · 2015-04-01 · 1 site observation

Efficacy of Once-Weekly Exenatide Versus Once or Twice Daily Insulin Detemir in Patients With Type 2 DiabetesNCT01003184 · 2009-10-01 · 1 site observation

RADICALS - Radiotherapy and Androgen Deprivation In Combination After Local SurgeryNCT00541047 · 2007-11-01 · 1 site observation

Etoposide and Cisplatin or Carboplatin as First-Line Chemotherapy With or Without Pravastatin in Treating Patients With Small Cell Lung CancerNCT00433498 · 2007-01-01 · 1 site observation

Dexamethasone and Supportive Care With or Without Whole-Brain Radiation Therapy in Treating Patients With Non-Small Cell Lung Cancer That Has Spread to the Brain and Cannot Be Removed By SurgeryNCT00403065 · 2006-10-01 · 1 site observation

Prostate Adenocarcinoma TransCutaneous HormonesNCT00303784 · 2006-03-01 · 1 site observation

Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast CancerNCT00326820 · 2006-01-01 · 1 site observation

Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By SurgeryNCT00301925 · 2005-12-16 · 1 site observation

Carboplatin or Docetaxel in Treating Women With Metastatic Genetic Breast CancerNCT00321633 · 2005-09-01 · 1 site observation

Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine for Advanced Colorectal Cancer or Breast CancerNCT00559858 · 2004-12-01 · 1 site observation

Radiation Therapy in Treating Women With Localized Breast CancerNCT00107497 · 2004-10-05 · 1 site observation

Anastrozole in Preventing Breast Cancer in Postmenopausal Women at Increased Risk of Breast CancerNCT00078832 · 2003-09-01 · 1 site observation

Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone PainNCT00082927 · 2003-04-01 · 1 site observation

Combination Chemotherapy in Treating Women With Breast Cancer Who Have Undergone SurgeryNCT00039546 · 2001-08-01 · 1 site observation

Combination Chemotherapy in Treating Women With Resected Breast CancerNCT00033683 · 2001-02-01 · 1 site observation

Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerNCT00005588 · 1999-01-01 · 1 site observation

Radiation Therapy After Surgery in Treating Women With Early Stage Breast CancerNCT00005587 · 1999-01-01 · 1 site observation

Standard Chemotherapy Compared With High-Dose Combination Chemotherapy and Peripheral Stem Cell Transplantation in Treating Women With Breast CancerNCT00002755 · 1995-11-01 · 1 site observation

Study of Blood and Tumor Samples From Men With an Inherited Risk of Prostate CancerNCT00959023 · 1993-06-01 · 1 site observation

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.